TOMSK, RUSSIA / RankWire.AI / – Russian researchers have created and evaluated a bioactive layer for titanium orthopedic implants. This material incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds associated with nitric oxide generation. Laboratory experiments indicated that human mesenchymal stem cells exhibited improved survival rates on coated titanium compared to uncoated metal. The team also analyzed the surface chemistry, hardness, thickness, and wettability of the coatings. Their peer-reviewed research concentrated on how different gas mixtures altered the coating’s properties and biological responses.
At Tomsk Polytechnic University, scientists produced these coatings using reactive magnetron sputtering within a vacuum chamber. They employed a hydroxyapatite target and modified the nitrogen and argon gas ratios during the deposition process. The study tested five different gas conditions, including pure nitrogen and pure argon, each producing distinct changes in the coating’s characteristics. The researchers examined surface structure, chemical composition, mechanical strength, and liquid contact. Subsequently, they exposed the coated titanium samples to human mesenchymal stem cells in a controlled laboratory environment.
Findings revealed that the amount of argon impacted various physical qualities of the coatings. Increased argon levels resulted in thicker, denser, and harder layers. Chemical analysis identified nitrogen-carbon and nitrogen-oxygen bonds in the modified surfaces. The team compared cell survival rates across the coated and uncoated titanium samples. Results demonstrated that the coated surfaces significantly improved cell viability during the study period. Additionally, they monitored gene expression related to early bone-cell formation to evaluate how the coating influenced cellular behavior.
Enhanced titanium coatings promote improved cell survival
The researchers observed that higher nitrogen content affected the activity of certain genes involved in early bone-cell differentiation, with changes becoming evident after seven days of cell cultivation. Despite these genetic shifts, the cells maintained their capacity to produce bone-like tissue. It is important to note that this study did not involve testing the coatings on humans nor did it measure clinical outcomes from implanted devices. Therefore, the results relate solely to laboratory performance and not to actual patient benefits from joint replacements or other orthopedic implants.
The assessment was conducted by scientists from Immanuel Kant Baltic Federal University and Siberian State Medical University. Researchers from Saint Petersburg State University also contributed to the broader project. This work examined how variations in coating composition influenced both material properties and cellular responses. Hydroxyapatite remains a popular choice for medical coatings because its calcium phosphate structure closely resembles the mineral component of human bone. The scientists utilized this base material while adjusting nitrogen exposure levels during the coating process.
Future investigations will explore prolonged biological effects
Following the initial seven-day evaluation, the research team plans to perform further laboratory and biological testing. They aim to observe stem cell behavior over periods spanning from 10 to 28 days and measure how rapidly the coatings dissolve. An additional component of their future work involves monitoring nitric oxide release into surrounding tissues in living organisms. These experiments were not part of the published study. Currently, the findings are limited to laboratory tests, coated titanium samples, and controlled cell experiments.
This research enhances understanding of how varying nitrogen and argon ratios affect calcium phosphate coatings on titanium implants. The scientists documented changes in coating thickness, density, hardness, chemical bonding, and cellular responses. Throughout their tests, coated samples consistently supported greater stem-cell survival than untreated titanium. However, the study remains in the preclinical phase and does not establish safety or efficacy for human use. Further research is needed to explore longer-term cell responses and nitric oxide release, which the current study did not address.